Xeltis’ CEO, Laurent Grandidier will present his insights on potential disruption in healthcare and life-science at this year’s UBS Disruptive Technology CEO Summit.
The meeting brings together over 300 Chairmen, CEOs, entrepreneurs, industry consultants, and financial investors to share their experiences as proven market disruptors. The third UBS Disruptive Technology CEO Summit is taking place in Hong Kong on Tuesday, September 26, 2017.
“Disruptive medical technology such as Xeltis’ will profoundly transform the healthcare landscape at all levels. I look forward to exchanging views with other forward-looking leaders on this topic,” commented Grandidier in anticipation to the meeting.
Learn more about Xeltis’ CEO, Laurent Grandidier with our CEO profile.
